Jessyka Wright, Biomedical Engineering Director,Christus Trinity Mother Frances, Tyler, Texas I enlisted in the US Army Reserves not long after high school and received training as a biomedical equipment technician (BMET). Over my first 10 months in the service, I attended labs and lectures Monday through Friday and worked on every piece of equipment —…
Here are five guidelines to help employers balance health outcomes and financial responsibility to ensure that GLP-1 coverage is effective, affordable, and aligned with improved health and workforce well-being for employees and their families. The post How Employers Can Build an Effective GLP-1 Strategy appeared first on MedCity News.
This brief provides an overview of these legal challenges and summarizes the key positions of the plaintiffs and the defendants, Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS).
It makes sense to approach some marketing efforts with skepticism. Scams, deepfakes, and deceptive social media posts are common, with people you don’t know seeking to profit from your behavior. But should people extend this same skepticism to pediatricians who advise vaccines for children? Health and Human Services Secretary Robert F. Kennedy Jr. said financial…
CHARLOTTE, N.C. — During the heat dome that blanketed much of the Southeast in June, Stacey Freeman used window units to cool her poorly insulated mobile home in Fayetteville, North Carolina. Over the winter, the 44-year-old mom relied on space heaters. In both instances, her energy bills reached hundreds of dollars a month. “Sometimes I…
OpenEvidence’s $12 billion valuation reflects investor confidence in its bottom-up, doctor-first model. It has driven rapid adoption, with more than 430,000 clinicians using the startup’s free AI medical search tool regularly. That scale is paired with targeted pharmaceutical advertising that’s already pushed the company past a $100 million revenue run rate. The post Thunderstruck By…
Now, with the ability to measure coronary inflammation through AI-enhanced CT scans and to more accurately determine a person’s risk of heart attack, we can intervene earlier and more effectively. The post Regulatory Shift Paves Way for AI-Driven Heart Disease Diagnosis appeared first on MedCity News.
LB Pharmaceuticals’ planned IPO will fund late-stage clinical development of LB-102, a once-daily pill designed to improve on the old Sanofi schizophrenia drug Solian. The IPO filing follow a corporate restructuring in May that cut the jobs of LB’s chief financial and scientific officers to streamline operations and extend its cash runway. The post With…
Transcarent is planning to acquire Accolade for $621 million, the companies announced Wednesday. The two companies are very complementary and the deal gives Accolade a chance to turn things around after struggling in the public market, experts say. The post Accolade Gets a Do-Over With Transcarent’s $621M Acquisition appeared first on MedCity News.
Editas Medicine says its in vivo gene-editing therapy for hemoglobinopathies has best-in-class potential, but the company plans to out-license or partner that program. Editas is shifting focusing to in vivo gene-editing therapies. The post Editas Medicine Seeks Partner for Ex Vivo Gene-Editing Program as Focus Turns to In Vivo R&D appeared first on MedCity News.